SAN FRANCISCO (MarketWatch) -- Biopure Corp. after Tuesday's closing bell said the Securities and Exchange Commission has granted final approval of its previously disclosed agreement to settle the ...

, charging the Cambridge, Mass., drug company with fraud relating to its efforts to develop an artificial blood substitute. The SEC said Wednesday the company and three officers engaged in a ...

said Wednesday that it expects to run out of money in eight weeks, adding that it must raise $19 million to keep operating through October. The announcement is the latest in a series of regulatory and ...

CAMBRIDGE, Mass., May 14 Biopure Corporation(Nasdaq: BPUR) today announced it has appointed Dechra Veterinary Products asexclusive distributor for Oxyglobin(R) solution [hemoglobin glutamer-200(bovine ...

With advanced manufacturing, BioPure’s BioClamp connector is manufactured to be 13% lighter than the previous model, resulting in a 26% reduction in carbon dioxide emissions across the full lifecycle ...

CAMBRIDGE, Mass., July 16 Biopure Corporation (Nasdaq: BPUR) announced today that it has filed a voluntary petition for relief under Chapter 11 of the United States Bankruptcy Code in the United ...

Howard Richman better hope there's no such thing as karma. The former BioPure vice president was sentenced last month to three years in prison for faking cancer to avoid an SEC investigation. The ...